secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0001193125-25-012236
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences stockholders approve amended equity plan adding 3.34M shares
------------------------------------------------------------------------------

- Stockholders approved A&R 2021 Equity Incentive Plan on Jan 24, 2025; 2.19M for, 0.47M against, 1.38M abstain.
- Plan adds 3,340,000 shares to reserve plus up to 44,093 from forfeited prior plan awards.
- Plan authorizes grants of options, SARs, restricted stock, RSUs, performance awards to employees, directors, consultants.
- Plan prohibits Exchange Programs (no repricing or cancellation of underwater awards without shareholder approval).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312525012236/0001193125-25-012236-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312525012236/d875887d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-012236

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer